Clinical Utility and Limitation of Diagnostic Ability for Different Degrees of Dysplasia of Intraductal Papillary Mucinous Neoplasms of the Pancreas Using <sup>18</sup>F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography
The diagnostic value of <sup>18</sup>F-fluorodeoxyglucose (FDG) uptake in the management of intraductal papillary mucinous neoplasms (IPMNs) of the pancreas remains unclear. This study aimed to assess the role of FDG uptake in the diagnosis of different degrees of dysplasia of IPMNs. We...
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/18/4633 |
id |
doaj-e30e2b1a5e3f44fb8efe7ec412d21d0e |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yuto Hozaka Hiroshi Kurahara Hideyuki Oi Tetsuya Idichi Yoichi Yamasaki Yota Kawasaki Kiyonori Tanoue Megumi Jinguji Masatoyo Nakajo Atsushi Tani Akihiro Nakajo Yuko Mataki Yoshihiko Fukukura Hirotsugu Noguchi Michiyo Higashi Takashi Yoshiura Akihide Tanimoto Takao Ohtsuka |
spellingShingle |
Yuto Hozaka Hiroshi Kurahara Hideyuki Oi Tetsuya Idichi Yoichi Yamasaki Yota Kawasaki Kiyonori Tanoue Megumi Jinguji Masatoyo Nakajo Atsushi Tani Akihiro Nakajo Yuko Mataki Yoshihiko Fukukura Hirotsugu Noguchi Michiyo Higashi Takashi Yoshiura Akihide Tanimoto Takao Ohtsuka Clinical Utility and Limitation of Diagnostic Ability for Different Degrees of Dysplasia of Intraductal Papillary Mucinous Neoplasms of the Pancreas Using <sup>18</sup>F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography Cancers IPMN FDG PET mural nodule high-grade dysplasia glucose transporter 1 |
author_facet |
Yuto Hozaka Hiroshi Kurahara Hideyuki Oi Tetsuya Idichi Yoichi Yamasaki Yota Kawasaki Kiyonori Tanoue Megumi Jinguji Masatoyo Nakajo Atsushi Tani Akihiro Nakajo Yuko Mataki Yoshihiko Fukukura Hirotsugu Noguchi Michiyo Higashi Takashi Yoshiura Akihide Tanimoto Takao Ohtsuka |
author_sort |
Yuto Hozaka |
title |
Clinical Utility and Limitation of Diagnostic Ability for Different Degrees of Dysplasia of Intraductal Papillary Mucinous Neoplasms of the Pancreas Using <sup>18</sup>F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography |
title_short |
Clinical Utility and Limitation of Diagnostic Ability for Different Degrees of Dysplasia of Intraductal Papillary Mucinous Neoplasms of the Pancreas Using <sup>18</sup>F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography |
title_full |
Clinical Utility and Limitation of Diagnostic Ability for Different Degrees of Dysplasia of Intraductal Papillary Mucinous Neoplasms of the Pancreas Using <sup>18</sup>F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography |
title_fullStr |
Clinical Utility and Limitation of Diagnostic Ability for Different Degrees of Dysplasia of Intraductal Papillary Mucinous Neoplasms of the Pancreas Using <sup>18</sup>F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography |
title_full_unstemmed |
Clinical Utility and Limitation of Diagnostic Ability for Different Degrees of Dysplasia of Intraductal Papillary Mucinous Neoplasms of the Pancreas Using <sup>18</sup>F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography |
title_sort |
clinical utility and limitation of diagnostic ability for different degrees of dysplasia of intraductal papillary mucinous neoplasms of the pancreas using <sup>18</sup>f-fluorodeoxyglucose-positron emission tomography/computed tomography |
publisher |
MDPI AG |
series |
Cancers |
issn |
2072-6694 |
publishDate |
2021-09-01 |
description |
The diagnostic value of <sup>18</sup>F-fluorodeoxyglucose (FDG) uptake in the management of intraductal papillary mucinous neoplasms (IPMNs) of the pancreas remains unclear. This study aimed to assess the role of FDG uptake in the diagnosis of different degrees of dysplasia of IPMNs. We retrospectively analyzed the following three points in 84 patients with IPMNs: (1) risk factors to predict high-grade dysplasia (HGD) and invasive carcinoma (INV); (2) the relationship between FDG uptake and glucose transporter 1 (GLUT-1) expression; and (3) the relationship between FDG uptake and the presence of mural nodules. The histopathological diagnosis was low-grade dysplasia (LGD) in 43 patients, HGD in 16, and INV in 25. The maximum standardized uptake value (SUV-max) was significantly higher in INV than in LGD/HGD (<i>p</i> < 0.0001, <i>p</i> = 0.0136). The sensitivity and specificity to discriminate INV from LGD/HGD were 80.0% and 86.2%, respectively, using the receiver operator characteristic curve, when the optimal cutoff score of SUV-max was set at 4.03. Those values were not different between HGD and LGD. More than half of HGD patients had low GLUT-1 expression. Taken together, FDG-PET/CT is useful in distinguishing between non-invasive and invasive IPMN. Our results offer critical information that may determine surgical treatment strategies. |
topic |
IPMN FDG PET mural nodule high-grade dysplasia glucose transporter 1 |
url |
https://www.mdpi.com/2072-6694/13/18/4633 |
work_keys_str_mv |
AT yutohozaka clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography AT hiroshikurahara clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography AT hideyukioi clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography AT tetsuyaidichi clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography AT yoichiyamasaki clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography AT yotakawasaki clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography AT kiyonoritanoue clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography AT megumijinguji clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography AT masatoyonakajo clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography AT atsushitani clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography AT akihironakajo clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography AT yukomataki clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography AT yoshihikofukukura clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography AT hirotsugunoguchi clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography AT michiyohigashi clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography AT takashiyoshiura clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography AT akihidetanimoto clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography AT takaoohtsuka clinicalutilityandlimitationofdiagnosticabilityfordifferentdegreesofdysplasiaofintraductalpapillarymucinousneoplasmsofthepancreasusingsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomography |
_version_ |
1717367886921596928 |
spelling |
doaj-e30e2b1a5e3f44fb8efe7ec412d21d0e2021-09-25T23:49:44ZengMDPI AGCancers2072-66942021-09-01134633463310.3390/cancers13184633Clinical Utility and Limitation of Diagnostic Ability for Different Degrees of Dysplasia of Intraductal Papillary Mucinous Neoplasms of the Pancreas Using <sup>18</sup>F-Fluorodeoxyglucose-Positron Emission Tomography/Computed TomographyYuto Hozaka0Hiroshi Kurahara1Hideyuki Oi2Tetsuya Idichi3Yoichi Yamasaki4Yota Kawasaki5Kiyonori Tanoue6Megumi Jinguji7Masatoyo Nakajo8Atsushi Tani9Akihiro Nakajo10Yuko Mataki11Yoshihiko Fukukura12Hirotsugu Noguchi13Michiyo Higashi14Takashi Yoshiura15Akihide Tanimoto16Takao Ohtsuka17Department of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanDepartment of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanDepartment of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanDepartment of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanDepartment of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanDepartment of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanDepartment of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanDepartment of Radiology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanDepartment of Radiology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanDepartment of Radiology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanDepartment of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanDepartment of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanDepartment of Radiology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanDepartment of Pathology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanDepartment of Pathology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanDepartment of Radiology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanDepartment of Pathology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanDepartment of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City 890-8520, JapanThe diagnostic value of <sup>18</sup>F-fluorodeoxyglucose (FDG) uptake in the management of intraductal papillary mucinous neoplasms (IPMNs) of the pancreas remains unclear. This study aimed to assess the role of FDG uptake in the diagnosis of different degrees of dysplasia of IPMNs. We retrospectively analyzed the following three points in 84 patients with IPMNs: (1) risk factors to predict high-grade dysplasia (HGD) and invasive carcinoma (INV); (2) the relationship between FDG uptake and glucose transporter 1 (GLUT-1) expression; and (3) the relationship between FDG uptake and the presence of mural nodules. The histopathological diagnosis was low-grade dysplasia (LGD) in 43 patients, HGD in 16, and INV in 25. The maximum standardized uptake value (SUV-max) was significantly higher in INV than in LGD/HGD (<i>p</i> < 0.0001, <i>p</i> = 0.0136). The sensitivity and specificity to discriminate INV from LGD/HGD were 80.0% and 86.2%, respectively, using the receiver operator characteristic curve, when the optimal cutoff score of SUV-max was set at 4.03. Those values were not different between HGD and LGD. More than half of HGD patients had low GLUT-1 expression. Taken together, FDG-PET/CT is useful in distinguishing between non-invasive and invasive IPMN. Our results offer critical information that may determine surgical treatment strategies.https://www.mdpi.com/2072-6694/13/18/4633IPMNFDGPETmural nodulehigh-grade dysplasiaglucose transporter 1 |